J. Biochem, 1998, Vol. 123, No. 6 1024-1030
© 1998 Japanese Biochemical Society
research-article |
VIP Induces the Translocation and Degradation of the
Subunit of Gs Protein in Rat Pituitary GH4C1 Cells

*Department of Molecular Biology, The Tokyo Metropolitan Institute of Medical Science 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113-8613
Division of Endocrinology and Metabolism, Jichi Medical School 3311-1 Yakushiji, Minamikawachi-machi, Kawachi-gun, Tochigi 329-0431
1To whom correspondence should be addressed. Fax: +81-3-5685-6609, E-mail: yajima{at}rinshoken.or.jp
It has been shown that G proteins are potential regulatory molecules in the transmembrane signaling cascade. The aim of this study was to examine the possibility of equivalent G-protein redistribution and/or down-regulation in a target cell upon agonist stimulation. Short-term (080 min) incubation of rat pituitary GH4C1 cells with vasoactive intestinal peptide (VIP, 0.1 µM) induced a decrease in the levels of Gs
in the membrane fraction, whereas immunoblot analysis and reconstitution assay of adenylyl cyclase clearly showed an increase in the amount of Gs
in the supernatant (cytosolic) fraction. The VIP-induced release of G proteins
subunits from membranes was specific for Gs
. The VIP-dependent release of Gs
from membranes was blocked by a VIP-receptor antagonist, (N-Ac-Tyr, D-Phe)-GRF(129)-NH2 (10 µM). Pituitary adenylate cyclase-activating polypeptide (PACAP) also stimulated the release of Gs
from membranes of GH4C1 cells. Furthermore, prolonged exposure of cells to VIP (0.1 µM) for 224 h caused a 2140% decrease in Gs
from membranes and a 6% increase in total Gs
in the cytosolic fraction. The effect of VIP was dose-dependent with ED50 values of 81.6±20.0 nM for down-regulation and 2.5±0.3 nM for translocation of Gs
. Concurrent treatment of GH4C1 cells with VIP and cycloheximide indicated that suppression of protein synthesis de novo did not mimic the effect of VIP. Moreover, the chase experiment of 35S-labeled Gs
clearly demonstrated a more rapid rate of decay in the cells maintained in the presence of the agonist. These data indicate that VIP-receptor activates Gs
protein and induces the release of Gs
from membranes along with its down-regulation in cellular levels.